Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FCMRH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,817
Award facts
- Contract value 100% obligated
- $32,816.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order from the Defense Logistics Agency (DLA) on May 7, 2025, for supply of Keytruda 100 mg/4 ml vials. This firm fixed-price delivery order, valued at $32,816.60, represents a single pharmaceutical product shipment with a completion deadline of May 29, 2025. The award was issued without a set-aside designation, reflecting the contractor's competitive position in federal pharmaceutical procurement markets. Performance will be conducted at the vendor's Park Ridge, Illinois facility.
This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with the DLA's SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC enables the DLA to procure a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status and extensive portfolio of pharmaceutical distribution capabilities to serve military health facilities with branded and generic prescription drugs, biologics, and specialty medications.
Quick answers
Who was awarded contract SPE2DB25FCMRH?
SPE2DB25FCMRH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 7, 2025.
How much is contract SPE2DB25FCMRH worth?
The government has obligated $32,817 on SPE2DB25FCMRH.
Is contract SPE2DB25FCMRH an order under another contract?
Yes. SPE2DB25FCMRH is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCMRH competed?
The extent of competition for SPE2DB25FCMRH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award